|
Effects of delirium on life after the intensive care unit: past, current, and future |
10/12/2020 - 12:00pm to 1:00pm EDT |
|
Life without Rhythm – The Evolution of Evidence behind Advanced Cardiovascular Life Support |
10/19/2020 - 12:00pm to 1:00pm EDT |
|
Cardiovascular and Renal Benefits of SGLT2 Inhibitor Therapy: Review of Clinical Practice Guidelines and Literature |
10/21/2020 - 12:00pm to 1:00pm EDT |
|
Care vs Pandemic. Recognizing the current impact and recommendations for oncology patient care |
10/23/2020 - 12:00pm to 1:00pm EDT |
|
Updates in the Acute Treatment of Cerebral Edema with Hyperosmolar Therapy |
10/26/2020 - 12:00pm to 1:00pm EDT |
|
Beta-Lactam Optimization in the ICU: A New Spin on Time Management |
11/09/2020 - 12:00pm to 1:00pm EST |
|
In the Driver’s Seat: Navigating the path less traveled in advanced non-small cell lung cancer |
11/16/2020 - 12:00pm to 1:00pm EST |
|
DOACs in special populations: Review of evidence for use in renal dysfunction and obesity |
11/23/2020 - 12:00pm to 1:00pm EST |
|
Changing Landscape of Triple Negative Breast Cancer Treatment – Updates on the use of Immunotherapy and PARP inhibitors |
10/11/2021 - 12:00pm to 1:00pm EDT |
|
What’s the Diff? Fidaxomicin vs. Vancomycin for the Treatment of C. Diff Infections |
10/18/2021 - 12:00pm to 1:00pm EDT |
Facebook
Twitter
LinkedIn
Forward